E-drug: Contents of Prescrire Internatonal, December 2001
-------------------------------------------------------------------------
[For new E-druggers: this is a very good journal, highy valued and
recommended by e.g. drug information centres. KM, moderator]
Prescrire international is the English language edition of la revue
Prescrire It contains comprehensive evaluations of new drugs and new
indication, and reviews of adverse effects and therapeutic interventions.
Prescrire International is published six times a year.
Since January 2001, we have created Solidarity Subscription Rates for low
income countries, so that health professionals in such countries can also
use our source of independent information . The Solidarity Rates apply to
all subscribers who live in low income countries, excluding pharmaceutical
companies.
Contents of Prescrire International,
December 2001 Volume 10 No 6
EDITORIAL
Real needs
NEW PRODUCTS
Bupropion (new preparation)
Poor risk-benefit ratio: do not prescribe or dispense
Topical becaplermin (new preparation)
May help some patients with diabetic ulcers
Oxcarbazepine (new preparation)
An alternative when carbamazepine fails to control partial epilepsy
Zanamivir (a second look)
Still no evidence of benefit
Docetaxel (new indication)
No first-line use in metastatic breast cancer
Galantamine (new preparation)
No better than other cholinesterase inhibitors
ADVERSE EFFECTS
NSAIDs and heart failure
Thioridazine and severe cardiac arrhythmia Severe systemic effects
withtopical fluorouraci
REVIEWS
Steroid therapy of acute ENT infections
Rarely indicated
In vitro fertilisation
Many unknowns
OUTLOOK
Safety of paracetamol packaging in the United Kingdom
SHORTCUTS
Trospium - Mofetil mycophenolate - Sevelamer
Eprosartan - Cetrorelix
Prescrire International is financed by subscription fees only. We cannot
provide free subscriptions. Send us your name and address if you want to
receive a sample issue.
An annual subscription covers six issues and a five-year index.
Standard Subscription Rates :
Individuals =3D 85 USD (91. 47 Euro)
students =3D 45 USD (45. 73 Euro)
Commercial institutions =3D 210 USD ( 228. 67 Euro)
Solidarity Subscription Rates for countries with GNP < 10,000 USD*
Individuals =3D 35 USD (38.11 Euro)
Students 21 USD (27. 87 Euro)
Institutions =3D 85 USD (91. 47 Euro) (pharmaceutical companies excepted)
*The following countries are not eligible for Solidarity Subscription
Rates: Australia, Austria, the Bahamas, Belgium, Brunei, Canada, Cyprus,
Denmark, Finland, France, Germany, Greece, Hong Kong, Iceland, Ireland,
Israel, Italy, Japan, Kuwait, Liechtenstein, Luxembourg, Monaco, the
Netherlands, New Zealand, Norway, Portugal, Qatar, Singapore, Spain, Swe
den, Switzerland, United Kingdom, United Arab Emirates, United States of
America.
Prescrire International
BP 459
75527 Paris Cedex 11
T=E9l : 33 1 49 23 72 65
Fax : 33 1 48 07 87 32=20
E-mail : international@prescrire.org
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: owner-e-drug@usa.healthnet.org
Information and archives: http://www.healthnet.org/programs/edrug.html